Long-term Clinical Outcomes After Retinal Artery Occlusion
Recruiting
Observational Study
Retinal Artery Occlusion
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 15,000 (estimated)
- Sponsor
- Chonnam National University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Retinal artery occlusion (RAO) is a rare but vision-threatening vascular disorder that is commonly caused by embolic events originating from the heart or carotid arteries. Patients with RAO are known to have an increased risk of subsequent cardiovascular and cerebrovascular events, including ischemic stroke and myocardial infarction. However, long-term outcomes and optimal medical treatment strate…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients newly diagnosed with retinal artery occlusion
Exclusion Criteria:
* Patients with a prior diagnosis of retinal artery occlusion before the study period.
* Patients diagnosed with giant cell arteritis.
Contacts